{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T04:42:50Z","timestamp":1684557770837},"reference-count":44,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CEOR"],"DOI":"10.2147\/ceor.s401687","type":"journal-article","created":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T00:05:19Z","timestamp":1684541119000},"page":"361-373","source":"Crossref","is-referenced-by-count":0,"title":["Assessing the Health Economic Outcomes from Commercially Insured Relapsing Multiple Sclerosis Patients Who Switched from Other Disease-Modifying Therapies to Teriflunomide, in the United States"],"prefix":"10.2147","volume":"Volume 15","author":[{"given":"Lita","family":"Araujo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srikanth","family":"Kyatham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristen G","family":"Bzdek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nupur","family":"Greene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2023,5]]},"reference":[{"key":"ref1","unstructured":"Multiple Sclerosis International Federation (MSIF). Atlas of MS 3rd edition. Part 1: mapping multiple sclerosis around the world: key epidemiology findings; 2020. Available from: https:\/\/www.msif.org\/wp-content\/uploads\/2020\/10\/Atlas-3rd-Edition-Epidemiology-report-EN-updated-30-9-20.pdf. Accessed September 20, 2022."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1177\/1352458520970841","volume":"26","author":"Walton","year":"2020","journal-title":"Mult Scler"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"e1029","DOI":"10.1212\/WNL.0000000000007035","volume":"92","author":"Wallin","year":"2019","journal-title":"Neurology"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"a028928","DOI":"10.1101\/cshperspect.a028928","volume":"8","author":"Klineova","year":"2018","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1212\/WNL.0000000000009636","volume":"94","author":"Lublin","year":"2020","journal-title":"Neurology"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S1474-4422(18)30443-5","volume":"18","author":"Wallin","year":"2019","journal-title":"Lancet Neurol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13690-021-00561-z","volume":"79","author":"Visser","year":"2021","journal-title":"Arch Public Health"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"e1810","DOI":"10.1212\/WNL.0000000000200150","volume":"98","author":"Bebo","year":"2022","journal-title":"Neurology"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1212\/WNL.0000000000005347","volume":"90","author":"Rae-Grant","year":"2018","journal-title":"Neurology"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"CD010968","DOI":"10.1002\/14651858.CD010968.pub2","volume":"11","author":"Zhang","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1016\/S0140-6736(12)61768-1","volume":"380","author":"Coles","year":"2012","journal-title":"Lancet"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"696","DOI":"10.3111\/13696998.2014.940422","volume":"17","author":"Bergvall","year":"2014","journal-title":"J Med Econ"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.4103\/1673-5374.239432","volume":"13","author":"Grand\u2019Maison","year":"2018","journal-title":"Neural Regen Res"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"647811","DOI":"10.3389\/fneur.2021.647811","volume":"12","author":"Hillert","year":"2021","journal-title":"Front Neurol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1177\/1756285616634247","volume":"9","author":"Haase","year":"2016","journal-title":"Ther Adv Neurol Disord"},{"key":"ref16","unstructured":"Sanofi. AUBAGIO\u00ae (teriflunomide) tablets [prescribing information]; 2022. Available from: https:\/\/products.sanofi.us\/aubagio\/aubagio.pdf. Accessed May 3, 2023."},{"key":"ref17","unstructured":"European Medicines Agency. Aubagio (teriflunomide) tablets [summary of product characteristics]; 2022. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/aubagio-epar-product-information_en.pdf. Accessed May 3, 2023."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1056\/NEJMoa1014656","volume":"365","author":"O\u2019Connor","year":"2011","journal-title":"N Engl J Med"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1212\/WNL.0000000000002441","volume":"86","author":"O\u2019Connor","year":"2016","journal-title":"Neurology"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S1474-4422(13)70308-9","volume":"13","author":"Confavreux","year":"2014","journal-title":"Lancet Neurol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"102438","DOI":"10.1016\/j.msard.2020.102438","volume":"46","author":"Miller","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.msard.2017.07.006","volume":"17","author":"Coyle","year":"2017","journal-title":"Mult Scler Relat Disord"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.msard.2019.03.022","volume":"31","author":"Coyle","year":"2019","journal-title":"Mult Scler Relat Disord"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"e0250820","DOI":"10.1371\/journal.pone.0250820","volume":"16","author":"Papp","year":"2021","journal-title":"PLoS One"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1756286419835077","DOI":"10.1177\/1756286419835077","volume":"12","author":"Kallmann","year":"2019","journal-title":"Ther Adv Neurol Disord"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.msard.2018.09.017","volume":"26","author":"Coyle","year":"2018","journal-title":"Mult Scler Relat Disord"},{"key":"ref27","unstructured":"Watson Health. IBM MarketScan Research Databases for life sciences researchers; 2023. Available from: https:\/\/www.ibm.com\/downloads\/cas\/OWZWJ0QO. Accessed: January 2, 2023."},{"key":"ref28","unstructured":"Code of Federal Regulations. TITLE 45: PUBLIC WELFARE (subtitle A subchapter A part 46 - protection of human subjects) [\u00a746.104(d)(4)(ii)]; 2018. Available from: https:\/\/www.ecfr.gov\/current\/title-45\/subtitle-A\/subchapter-A\/part-46. Accessed January 19, 2023."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"e0231846","DOI":"10.1371\/journal.pone.0231846","volume":"15","author":"Ohlmeier","year":"2020","journal-title":"PLoS One"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/1472-6963-13-131","volume":"13","author":"Raimundo","year":"2013","journal-title":"BMC Health Serv Res"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"469","DOI":"10.18553\/jmcp.2002.8.6.469","volume":"8","author":"Ollendorf","year":"2002","journal-title":"J Manag Care Pharm"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"618","DOI":"10.3111\/13696998.2010.523670","volume":"13","author":"Chastek","year":"2010","journal-title":"J Med Econ"},{"key":"ref33","unstructured":"U.S. Bureau of Labor Statistics. CPI Medical care services (2013\u20132020); 2020. Available from: https:\/\/www.bls.gov\/cpi\/data.htm. Accessed September 20, 2022."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"e0210417","DOI":"10.1371\/journal.pone.0210417","volume":"14","author":"Duquette","year":"2019","journal-title":"PLoS One"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3111\/13696990903579501","volume":"13","author":"Reynolds","year":"2010","journal-title":"J Med Econ"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","volume":"83","author":"Lublin","year":"2014","journal-title":"Neurology"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2147\/CEOR.S55779","volume":"6","author":"Bonafede","year":"2013","journal-title":"Clinicoecon Outcomes Res"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s41669-017-0035-2","volume":"2","author":"Nicholas","year":"2018","journal-title":"Pharmacoecon Open"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"102521","DOI":"10.1016\/j.msard.2020.102521","volume":"46","author":"Vermersch","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"711","DOI":"10.3111\/13696998.2015.1044276","volume":"18","author":"Yermakov","year":"2015","journal-title":"J Med Econ"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.2147\/PPA.S67253","volume":"8","author":"Liz\u00e1n","year":"2014","journal-title":"Patient Prefer Adherence"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"251","DOI":"10.2147\/CEOR.S130334","volume":"9","author":"Burks","year":"2017","journal-title":"Clinicoecon Outcomes Res"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1111\/j.1468-1331.2011.03648.x","volume":"19","author":"R\u00edo","year":"2012","journal-title":"Eur J Neurol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol"}],"container-title":["ClinicoEconomics and Outcomes Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=89849","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=89849","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T00:05:28Z","timestamp":1684541128000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/assessing-the-health-economic-outcomes-from-commercially-insured-relap-peer-reviewed-fulltext-article-CEOR"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":44,"URL":"https:\/\/doi.org\/10.2147\/ceor.s401687","relation":{},"ISSN":["1178-6981"],"issn-type":[{"value":"1178-6981","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5]]}}}